HERBALIFE LTD's ticker is HLF and the CUSIP is G4412G101. A total of 257 filers reported holding HERBALIFE LTD in Q4 2020. The put-call ratio across all filers is 2.55 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $14 | +7.7% | 1 | 0.0% | 0.00% | – |
| Q2 2023 | $13 | -18.8% | 1 | 0.0% | 0.00% | – |
| Q1 2023 | $16 | +6.7% | 1 | 0.0% | 0.00% | – |
| Q4 2022 | $15 | – | 1 | 0.0% | 0.00% | – |
| Q3 2022 | $0 | – | 1 | 0.0% | 0.00% | – |
| Q2 2022 | $0 | – | 1 | 0.0% | 0.00% | – |
| Q1 2022 | $0 | – | 1 | 0.0% | 0.00% | – |
| Q4 2021 | $0 | – | 1 | 0.0% | 0.00% | – |
| Q3 2021 | $0 | – | 1 | 0.0% | 0.00% | – |
| Q2 2021 | $0 | -100.0% | 1 | -98.6% | 0.00% | – |
| Q1 2021 | $3,000 | 0.0% | 70 | +27.3% | 0.00% | – |
| Q4 2020 | $3,000 | 0.0% | 55 | 0.0% | 0.00% | – |
| Q3 2020 | $3,000 | -85.0% | 55 | -80.7% | 0.00% | -100.0% |
| Q3 2013 | $20,000 | -37.5% | 285 | -57.2% | 0.00% | 0.0% |
| Q3 2012 | $32,000 | +6.7% | 666 | +7.6% | 0.00% | 0.0% |
| Q2 2012 | $30,000 | -49.2% | 619 | -27.6% | 0.00% | -50.0% |
| Q1 2012 | $59,000 | +51.3% | 855 | +12.9% | 0.00% | 0.0% |
| Q4 2011 | $39,000 | +50.0% | 757 | +53.9% | 0.00% | +100.0% |
| Q3 2011 | $26,000 | +23.8% | 492 | +35.2% | 0.00% | 0.0% |
| Q2 2011 | $21,000 | +90.9% | 364 | +163.8% | 0.00% | – |
| Q1 2011 | $11,000 | -8.3% | 138 | -52.7% | 0.00% | -100.0% |
| Q4 2009 | $12,000 | – | 292 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BlueDrive Global Investors LLP | 850,028 | $25,807,000 | 11.41% |
| Alua Capital Management LP | 5,353,223 | $162,524,000 | 11.12% |
| Route One Investment Company, L.P. | 10,043,232 | $304,913,000 | 9.50% |
| Bronte Capital Management Pty Ltd. | 2,962,635 | $89,946,000 | 7.56% |
| WINDACRE PARTNERSHIP LLC | 10,003,500 | $303,706,000 | 6.38% |
| CAS Investment Partners, LLC | 2,907,762 | $88,280,000 | 5.91% |
| Deccan Value Investors L.P. | 3,062,839 | $92,988,000 | 4.74% |
| JABODON PT CO | 170,332 | $5,171,000 | 2.35% |
| 683 Capital Management, LLC | 1,440,597 | $43,737,000 | 2.34% |
| Patient Capital Management, LLC | 194,300 | $5,899,000 | 2.00% |